phosphorylcholine has been researched along with Myocardial Ischemia in 4 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| " We therefore examined if HDL-associated sphingosylphosphorylcholine (SPC) reduces infarct size in a mouse model of transient myocardial ischemia/reperfusion." | 7.76 | Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury. ( Chun, J; Echtermeyer, F; Herrgott, I; Herzog, C; Hildebrand, R; Johanning, K; Larmann, J; Levkau, B; Mersmann, J; Müller, FU; Schmitz, M; Theilmeier, G; Winterhalter, M, 2010) |
| " We therefore examined if HDL-associated sphingosylphosphorylcholine (SPC) reduces infarct size in a mouse model of transient myocardial ischemia/reperfusion." | 3.76 | Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury. ( Chun, J; Echtermeyer, F; Herrgott, I; Herzog, C; Hildebrand, R; Johanning, K; Larmann, J; Levkau, B; Mersmann, J; Müller, FU; Schmitz, M; Theilmeier, G; Winterhalter, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yao, Y | 1 |
| Zhou, J | 1 |
| Lu, C | 1 |
| Sun, W | 1 |
| Kong, W | 1 |
| Zhao, J | 1 |
| Herzog, C | 1 |
| Schmitz, M | 1 |
| Levkau, B | 1 |
| Herrgott, I | 1 |
| Mersmann, J | 1 |
| Larmann, J | 1 |
| Johanning, K | 1 |
| Winterhalter, M | 1 |
| Chun, J | 1 |
| Müller, FU | 1 |
| Echtermeyer, F | 1 |
| Hildebrand, R | 1 |
| Theilmeier, G | 1 |
| Galli, M | 1 |
| Bartorelli, A | 1 |
| Bedogni, F | 1 |
| DeCesare, N | 1 |
| Klugmann, S | 1 |
| Maiello, L | 1 |
| Miccoli, F | 1 |
| Moccetti, T | 1 |
| Onofri, M | 1 |
| Paolillo, V | 1 |
| Pirisi, R | 1 |
| Presbitero, P | 1 |
| Sganzerla, P | 1 |
| Viecca, M | 1 |
| Zerboni, S | 1 |
| Lanteri, G | 1 |
| Choy, PC | 1 |
| Chan, M | 1 |
| Hatch, G | 1 |
| Man, RY | 1 |
1 trial available for phosphorylcholine and Myocardial Ischemia
| Article | Year |
|---|---|
Italian BiodivYsio open registry (BiodivYsio PC-coated stent): study of clinical outcomes of the implant of a PC-coated coronary stent.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Cor | 2000 |
3 other studies available for phosphorylcholine and Myocardial Ischemia
| Article | Year |
|---|---|
MicroRNA-155-5p/EPAS1/interleukin 6 pathway participated in the protection function of sphingosylphosphorylcholine to ischemic cardiomyocytes.
Topics: Animals; Apoptosis; Base Sequence; Basic Helix-Loop-Helix Transcription Factors; Cardiotonic Agents; | 2021 |
Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury.
Topics: Animals; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart; Humans; Lipoproteins, HDL; Lys | 2010 |
Phosphatidylcholine metabolism in ischemic and hypoxic hearts.
Topics: Adenosine Triphosphate; Animals; Biological Transport; Cell Hypoxia; Choline; Choline Kinase; Cholin | 1992 |